nach oben

Inflammopharmacology

Erschienen in:

01.12.2013 | Research Article

Thymoquinone attenuates cyclophosphamide-induced pulmonary injury in rats

verfasst von: Ghada M. Suddek, Nora A. Ashry, Nariman M. Gameil

Erschienen in: Inflammopharmacology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

Antioxidant therapy may be useful in diseases with impaired oxidant–antioxidant balance. This study was designed to examine the effects of thymoquinone (TQ), an anti-inflammatory, antioxidant agent against cyclophosphamide (CP)-induced pulmonary oxidative damage.

Materials and methods

Male Sprague-Dawley rats were categorized into four groups. Group I was control. Group II received TQ (100 mg/kg/day, p.o.) for 14 consecutive days. Group III was injected once with CP (150 mg/kg, i.p.). Group IV received TQ for 7 consecutive days, before and after CP injection. The parameters of study were tissue oxidant/antioxidant biomarkers and histological changes in rat lungs.

Results

A single intraperitoneal injection of CP markedly altered the levels of several biomarkers in lung homogenates. Significant increases in the content of lipid peroxides in lung were seen that paralleled the decreased levels of reduced glutathione. Cyclophosphamide increased the level of serum biomarkers: total protein, lactate dehydrogenase, and tumor necrosis factor-alpha (TNF-α). Treatment of rats with TQ 7 days before and after cyclophosphamide injection significantly attenuated the alterations in lung and serum biomarkers associated with inflammatory reactions, with less lipid peroxidation and restoration of antioxidants. Moreover, TQ attenuated the secretion of pro-inflammatory cytokine, TNF-α in rat serum. In addition, TQ effectively alleviated CP-induced histopathological changes in lung tissue.

Discussion and conclusion

Our results suggest that TQ produces a protective mechanism against CP-induced pulmonary damage and suggest a role of oxidative stress and inflammation in the pathogenesis.

Alenzi FQ, El-Bolkiny Yel-S, Salem ML (2010) Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide. Br J Biomed Sci 67:20–28

Arslan N, Miller TR, Dehdashti F, Battafarano RJ, Siegel BA (2002a) Evaluation of response to neoadjuvant therapy by quantitative 2-deoxy-2 (18F), fluoro-d-glucose with positron emission tomography in patients with esophageal cancer. Mol Imaging Biol 4:301–310PubMedCrossRef

Arslan SO, Zerin M, Vural H, Coskun A (2002b) The effect of melatonin on bleomycin-induced pulmonary fibrosis in rats. J Pineal Res 32:21–25PubMedCrossRef

Badary OA (1999) Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. J Ethnopharmacol 67:135–142PubMedCrossRef

Badary OA, Taha RA, Gamal el-Din AM, Abdel-Wahab MH (2003) Thymoquinone is a potent superoxide anion scavenger. Drug Chem Toxicol 26:87–98PubMedCrossRef

Bowler RP, Nicks M, Warnick K, Crapo JD (2002) Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis. Am J Physiol 282:L719–L726CrossRef

Bukowski RM (1996) The need for cytoprotection. Eur J Cancer 32A(Suppl 4):S2–S4PubMedCrossRef

Chehl N, Chipitsyna G, Gong Q, Yeo CJ, Arafat HA (2009) Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford) 11:373–381CrossRef

Daba MH, Abdel-Aziz AH, Moustafa AM, Al-Majed AA, Al-Shabanah OA, El-Kashef HA (2002) Effects of l-carnitine and Ginkgo Biloba extract (EGb 761) in experimental bleomycin-induced lung fibrosis. Pharmacol Res 45:461–467PubMedCrossRef

Daniel WW (1991) Hypothesis testing. In: Biostatistics: a foundation for analysis in the health sciences, 5th edn. Wiley, New York

Das UB, Mallick M, Debnath JM, Ghosh D (2002) Protective effect of ascorbic acid on cyclophosphamide-induced testicular gametogenic and androgenic disorder in male rats. Asian J Androl 4:201–207PubMed

Donato ML, Aleman A, Champlin RE et al (2004) Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant 33:1219–1224PubMedCrossRef

El Gazzar M, El Mezayen R, Marecki JC, Nicolls MR, Canastar A, Dreskin SC (2006) Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. Int Immunopharmacol 6:1135–1142PubMedCrossRef

El Gazzar M, El Mezayen R, Nicolls MR, Dreskin SC (2007) Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation. Biochim Biophys Acta 1770:556–564PubMedCrossRef

Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77PubMedCrossRef

El-Mahmoudy A, Shimizu Y, Shiina T, Matsuyama H, Nikami H, Takewaki T (2005) Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone. Acta Diabetol 42:23–30PubMedCrossRef

Fraiser LH, Kanekal S, Kehrer JP (1991) Cyclophosphamide toxicity; characterizing and avoiding the problem. Drug 42:781–795CrossRef

Ghosh D, Das UB, Ghosh S, Mallick M, Debnath J (2002) Testicular gametogenic and steroidogenic activities in cyclophosphamide treated rat: a correlative study with testicular oxidative stress. Drug Chem Toxicol 25:281–292PubMedCrossRef

Hales BF (1982) Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein. Cancer Res 42:3016–3021PubMed

Hirano A, Shimizu T, Watanabe O, Kinoshita J, Kimura K, Kamimura M, Domoto K, Aiba M, Ogawa K (2008) Epirubicin and cyclophosphamide followed by docetaxel as primary systemic chemotherapy in locally advanced breast cancer. Anticancer Res 28:4137–4142PubMed

Khattab MM, Nagi MN (2007) Thymoquinone supplementation attenuates hypertension and renal damage in nitric oxide deficient hypertensive rats. Phytother Res 21:410–414PubMedCrossRef

Kim S, Tannock I, Sridhar S, Seki J, Bordeleau L (2012) Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients. J Oncol Pharm Pract 18:311–315PubMedCrossRef

Kumar S, Dhankhar N, Kar V, Shrivastava M, Shrivastava S (2011) Myocardial injury provoked by cyclophosphamide, protective aspect of hesperidin in rats. Int J Res Pharm Biomed Sci 2:1288–1296

Levine MN, Pritchard KI, Bramwell VH, Shepherd LE, Tu D, Paul N (2005) Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5. J Clin Oncol 23:5166–5170PubMedCrossRef

Malik SW, Myers JL, DeRemee RA, Specks U (1996) Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med 154:1851–1856PubMedCrossRef

Manda K, Bhatia AL (2003) Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice. Cell Biol Toxicol 19:367–372PubMedCrossRef

Marklund SL (1985) Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB/c mice. Mutat Res 148:129–134PubMedCrossRef

McDiarmid MA, Iype PT, Kolodner K, Jacobson-Kram D, Strickland PT (1991) Evidence for acrolein-modified DNA in peripheral blood leucocytes of cancer patients treated with cyclophosphamide. Mutat Res 248:93–99PubMedCrossRef

Nagi MN, Mansour MA (2000) Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol Res 41:283–289PubMedCrossRef

Nagi MN, Al-Shabanah OA, Hafez MM, Sayed-Ahmed MM (2011) Thymoquinone supplementation attenuates cyclophosphamide-induced cardiotoxicity in rats. J Biochem Mol Toxicol 25:S135–S142CrossRef

Nicolini A, Mancini P, Ferrari P et al (2004) Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC). Biomed Pharmacother 58:447–450PubMed

O’Neil CA, Giri SN (1992) Effect of niacin on bleomycin-induced increases in myeloperoxidase, prolyl hydroxylase, and superoxide dismutase activities and collagen accumulation in the lungs of hamsters. J Biochem Toxicol 7:229–239CrossRef

Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMedCrossRef

Patel JM (1987) Stimulation of cyclophosphamide-induced pulmonary microsomal lipid peroxidation by oxygen. Toxicology 45:79–91PubMedCrossRef

Patel JM (1990) Metabolism and pulmonary toxicity of cyclophosphamide. Pharmacol Ther 47:137–146PubMedCrossRef

Patel JM, Block ER (1985) Cyclophosphamide-induced depression of the antioxidant defense mechanisms of the lung. Exp Lung Res 8:153–165PubMedCrossRef

Ragheb A, Attia A, Eldin WS, Elbarbry F, Gazarin S, Shoker A (2009) The protective effect of thymoquinone, an anti-oxidant and anti-inflammatory agent, against renal injury: a review. Saudi J Kidney Dis Transpl 20:741–752 ReviewPubMed

Rao R, Shammo JM, Enschede SH et al (2005) The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade non-Hodgkin’s lymphoma. Clin Lymphoma 6:26–30PubMedCrossRef

Stankiewicz A, Skrzydlewska E, Makieła M (2002) Effects of amifostine on liver oxidative stress caused by cyclophosphamide administration to rats. Drug Metabol Drug Interact 19:67–82PubMedCrossRef

Sulkowska M, Sulkowski S (1997) The effect of pentoxifylline on ultrastructural picture of type II alveolar epithelial cells and generation of reactive oxygen species during cyclophosphamide-induced lung injury. J Submicrosc Cytol Pathol 29:487–496PubMed

Sulkowska M, Sulkowski S (1998) Alveolar cells in cyclophosphamide-induced lung injury. An ultrastructural analysis of type II alveolar epithelial cells in situ. Histol Histopathol 13:13–20PubMed

Sulkowska M, Skrzydlewska E, Sobaniec-Łotowska M et al (2002) Effect of cyclophosphamide-induced generation reactive oxygen forms on ultrastructure of the liver and lung. Bull Vet Inst Pulawy 46:239–246

Sundstrom S, Bremnes RM, Kaasa S, Aasebo U, Aamdal S (2005) Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen). Lung Cancer 48:251–261PubMedCrossRef

Tannehill SP, Mehta MP (1996) Amifostine and radiation: past, present and future. Semin Oncol 23:69–77PubMed

Tekeoglu I, Dogan A, Demiralp L (2006) Effects of thymoquinone (volatile oil of black cumin) on rheumatoid arthritis in rat models. Phytother Res 20:869–871PubMedCrossRef

Venkatesan N, Chandrakasan G (1995) Modulation of cyclophosphamide-induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol Cell Biochem 142:79–87PubMedCrossRef

Vouldoukis I, Lacan D, Kamate C, Coste P, Calenda A, Mazier D, Conti M, Dugas B (2004) Antioxidant and anti-inflammatory properties of a Cucumis melo LC. extract rich in superoxide dismutase activity. J Ethnopharmacol 94:67–75PubMedCrossRef

Woo CC, Kumar AP, Sethi G, Tan KHB (2012) Thymoquinone potential cure for inflammatory disorders and cancer. Biochem Pharmacol 83:443–451PubMedCrossRef

Zhang J, Tian Q, Zhou S (2006) Clinical pharmacology of cyclophosphamide and ifosfamide. Current Drug Therapy 1:55–84CrossRef

Titel: Thymoquinone attenuates cyclophosphamide-induced pulmonary injury in rats
verfasst von: Ghada M. Suddek
Nora A. Ashry
Nariman M. Gameil
Publikationsdatum: 01.12.2013
Verlag: Springer Basel
Erschienen in: Inflammopharmacology / Ausgabe 6/2013
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-012-0160-6

Springer Medizin

Abstract

Objective

Materials and methods

Results

Discussion and conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2013

Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management

The anti-inflammatory effect of diclofenac is considerably augmented by topical capsaicinoids-containing patch in carrageenan-induced paw oedema of rat

The multiple faces of CCL13 in immunity and inflammation

Erratum to: Atorvastatin exhibits anti-inflammatory and anti-oxidant properties in adjuvant-induced monoarthritis

Effect of diclofenac and antidepressants on the inflammatory response in astrocyte cell culture

Comparison of the ability of chondroitin sulfate derived from bovine, fish and pigs to suppress human osteoclast activity in vitro